Search Results - "Condit, Richard C"
-
1
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
Published in Vaccine (21-05-2021)“…The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral…”
Get full text
Journal Article -
2
Pearls collections: What we can learn about infectious disease and cancer
Published in PLoS pathogens (01-03-2018)“…[...]a contribution by Cattaneo and Russell probes the use and potential of viruses to treat cancer, using as an example a remarkable success story on the use…”
Get full text
Journal Article -
3
Editorial introduction to “Giant Viruses” special issue of Virology
Published in Virology (New York, N.Y.) (01-10-2014)Get full text
Journal Article -
4
In a nutshell: structure and assembly of the vaccinia virion
Published in Advances in virus research (2006)“…Poxviruses comprise a large family of viruses characterized by a large, linear dsDNA genome, a cytoplasmic site of replication and a complex virion morphology…”
Get more information
Journal Article -
5
Whence feral vaccinia?
Published in Emerging infectious diseases (01-06-2010)Get full text
Journal Article -
6
Innate immune response of human plasmacytoid dendritic cells to poxvirus infection is subverted by vaccinia E3 via its Z-DNA/RNA binding domain
Published in PloS one (14-05-2012)“…Plasmacytoid dendritic cells (pDCs) play important roles in antiviral innate immunity by producing type I interferon (IFN). In this study, we assess the immune…”
Get full text
Journal Article -
7
Biological Characterization and Next-Generation Genome Sequencing of the Unclassified Cotia Virus SPAn232 (Poxviridae)
Published in Journal of Virology (01-05-2012)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
8
Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus
Published in Journal of Virology (01-05-2002)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
9
Surf and turf: mechanism of enhanced virus spread during poxvirus infection
Published in Viruses (01-05-2010)“…Commentary on Doceul, V.; Hollinshead, M.; van der Linden, L.; Smith, G.L. Repulsion of superinfecting virions: a mechanism for rapid virus spread…”
Get full text
Journal Article -
10
Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization
Published in Virology (New York, N.Y.) (15-01-2015)“…Abstract The vaccinia virion is a membraned, slightly flattened, barrel-shaped particle, with a complex internal structure featuring a biconcave core flanked…”
Get full text
Journal Article -
11
Purification and Properties of the Vaccinia Virus mRNA Processing Factor
Published in The Journal of biological chemistry (29-02-2008)“…The mRNAs encoding the vaccinia virus F17 protein and the cowpox A-type inclusion protein are known to possess sequence-homogeneous 3′ ends, generated by a…”
Get full text
Journal Article -
12
Leaf turgor loss point shapes local and regional distributions of evergreen but not deciduous tropical trees
Published in The New phytologist (01-04-2021)“…Summary The effects of climate change on tropical forests will depend on how diverse tropical tree species respond to drought. Current distributions of…”
Get full text
Journal Article -
13
The vaccinia virus E6 protein influences virion protein localization during virus assembly
Published in Virology (New York, N.Y.) (01-08-2015)“…Abstract Vaccinia virus mutants in which expression of the virion core protein gene E6R is repressed are defective in virion morphogenesis. E6 deficient…”
Get full text
Journal Article -
14
-
15
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
Published in Vaccine (22-07-2020)“…Nucleic acid (DNA and RNA) vaccines are among the most advanced vaccines for COVID-19 under development. The Brighton Collaboration Viral Vector Vaccines…”
Get full text
Journal Article -
16
Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid
Published in Journal of virology (01-12-2014)“…Electron micrographs from the 1960s revealed the presence of an S-shaped tubular structure in the center of the vaccinia virion core. Recently, we showed that…”
Get full text
Journal Article -
17
An improved high pressure freezing and freeze substitution method to preserve the labile vaccinia virus nucleocapsid
Published in Journal of structural biology (01-07-2016)“…In recent years, high pressure freezing and freeze substitution have been widely used for electron microscopy to reveal viral and cellular structures that are…”
Get full text
Journal Article -
18
Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk/benefit assessment
Published in Vaccine (01-01-2015)“…Highlights • The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) evaluates vaccine safety. • Many recombinant viral vectored vaccines…”
Get full text
Journal Article -
19
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines
Published in Vaccine (17-11-2020)“…Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety…”
Get full text
Journal Article -
20
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines
Published in Vaccine (31-07-2020)“…Several protein vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group…”
Get full text
Journal Article